Search research articles
Contact Us
Filters
Showing results (11-20 of 20) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Hematology
|
August 11, 2017
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients
Ayalew Tefferi, Silvia Betti, Daniela Barraco, et al.
Blood Advances
|
August 11, 2020
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
Giacomo Coltro, Giada Rotunno, Lara Mannelli, et al.
American Journal of Hematology
|
March 26, 2022
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis
Francesco Mannelli, Sara Bencini, Giacomo Coltro, et al.
Blood Cancer Journal
|
February 27, 2020
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, et al.
Clinical and Experimental Medicine
|
February 18, 2020
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
Giacomo Coltro, Francesco Mannelli, Federica Vergoni, et al.
Blood Cancer Journal
|
December 13, 2021
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Paola Guglielmelli, Giuseppe G Loscocco, Carmela Mannarelli, et al.
British Journal of Haematology
|
January 17, 2020
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera
Ayalew Tefferi, Paola Guglielmelli, Terra L Lasho, et al.
Leukemia
|
December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
Cancer Medicine
|
January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Nature Communications
|
May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan M Carr, Denis Vorobyev, Terra Lasho, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 20) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 20 results.
American Journal of Hematology
|
August 11, 2017
Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients
Ayalew Tefferi, Silvia Betti, Daniela Barraco, et al.
Blood Advances
|
August 11, 2020
RAS/CBL mutations predict resistance to JAK inhibitors in myelofibrosis and are associated with poor prognostic features
Giacomo Coltro, Giada Rotunno, Lara Mannelli, et al.
American Journal of Hematology
|
March 26, 2022
Integration of multiparameter flow cytometry score improves prognostic stratification provided by standard models in primary myelofibrosis
Francesco Mannelli, Sara Bencini, Giacomo Coltro, et al.
Blood Cancer Journal
|
February 27, 2020
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis
Paola Guglielmelli, Alessandra Carobbio, Elisa Rumi, et al.
Clinical and Experimental Medicine
|
February 18, 2020
Extramedullary blastic transformation of primary myelofibrosis in the form of disseminated myeloid sarcoma: a case report and review of the literature
Giacomo Coltro, Francesco Mannelli, Federica Vergoni, et al.
Blood Cancer Journal
|
December 13, 2021
JAK2V617F variant allele frequency >50% identifies patients with polycythemia vera at high risk for venous thrombosis
Paola Guglielmelli, Giuseppe G Loscocco, Carmela Mannarelli, et al.
British Journal of Haematology
|
January 17, 2020
Mutation-enhanced international prognostic systems for essential thrombocythaemia and polycythaemia vera
Ayalew Tefferi, Paola Guglielmelli, Terra L Lasho, et al.
Leukemia
|
December 15, 2019
Clinical, molecular, and prognostic correlates of number, type, and functional localization of TET2 mutations in chronic myelomonocytic leukemia (CMML)-a study of 1084 patients
Giacomo Coltro, Abhishek A Mangaonkar, Terra L Lasho, et al.
Cancer Medicine
|
January 28, 2023
Assessment of the efficacy and tolerability of ruxolitinib for the treatment of myelofibrosis patients in a real-life setting: An Italian MYNERVA Project
Giacomo Coltro, Emanuela Sant'Antonio, Giuseppe A Palumbo, et al.
Nature Communications
|
May 19, 2021
RAS mutations drive proliferative chronic myelomonocytic leukemia via a KMT2A-PLK1 axis
Ryan M Carr, Denis Vorobyev, Terra Lasho, et al.
Page
of 2